NASDAQ:LFMD
LifeMD, Inc.
LifeMD, Inc.'s revenue grew 25.3% in fiscal 2025 to $194.1M while operating margin rose to −4.0%, its highest in 10 years. Free cash flow was $6.4M, 3.3% of revenue, and the diluted share count rose 9.5%.Summary generated from LifeMD, Inc.'s SEC filings. Latest annual report filed Mar 10, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$194.1M
Revenue growth+25.3%
Revenue, 5-yr CAGR+39.1%
Gross margin85.7%
Operating margin−4.0%
Net margin7.4%
ROICn/a
Return on equity204.0%
Debt / equityn/a
Free cash flow$6.4M
FCF margin3.3%
Share count change+9.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 93 | 119 | 153 | 155 | 194 |
| Operating income | −54 | −43 | −14 | −20 | −8 |
| Net income | −61 | −46 | −21 | −21 | 14 |
| Free cash flow | −33 | −23 | 9 | 16 | 6 |
Recent filings
- 8-KRegulation FD disclosure
Sep 15, 2026 - 4Insider transaction report
Aug 18, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 5, 2026 - 8-KResults of operations and financial condition
Aug 5, 2026 - 8-KRegulation FD disclosure
Jun 22, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 6, 2026 - 8-KResults of operations and financial condition
May 6, 2026